Greenbrook

Greenbrook TMS owns and operates healthcare centers providing repetitive transcranial magnetic stimulation therapy (TMS) for the treatment of major depressive disorder (MDD) and other neurological diseases. Local electromagnetic stimulation is given during TMS therapy to certain brain areas known to be directly involved in mood regulation. Spravato is promoted to treat depressive symptoms in adults with MDD who have suicidal thoughts or behaviors as well as adults with treatment-resistant depression. In order to give patients a thorough treatment experience, Greenbrook handles insurance coverage and handles logistics while keeping the clients informed and involved in the procedure.

Sasha Cucuz

Executive Director

Alan Peck

Executive Director

1 past transactions

Achieve TMS Centers

Acquisition in 2019
Achieve TMS Centers, established in 2016 and based in San Diego, California, specializes in providing transcranial magnetic stimulation (TMS) therapy for treating depression, PTSD, and anxiety. As of 2019, it operates as a subsidiary of TMS Neurohealth Centers Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.